Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-β–treated alloreactive T cells that do not induce graft-versus-host disease
Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Bruce R. Blazar(University of Minnesota Medical Center), Jay C. Zeller(San Raffaele University of Rome), William J. Murphy(University of California Davis Medical Center), Satwant K. Narula(AGCO (United Kingdom)), Maria Grazia Roncarolo(Stanford University), Zong-Ming Chen(San Raffaele University of Rome), Alla Berezovskaya(Ontario Institute for Cancer Research)
Cited by 47
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k